- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04241874
PEEP and Spontaneous Breathing During ARDS (EARDS)
Effects of Positive End-expiratory Pressure With and Without Inspiratory Synchronization During Moderate to Severe ARDS
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective, physiological, randomized, cross-over study will be conducted in the 20-bed general ICU of the Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy. Patients with ARDS will be screened for eligibility. ARDS will be defined according to the Berlin Definition.
Intubated patients fulfilling ARDS criteria, undergoing assisted ventilation as per clinical decision and exhibiting intense inspiratory effort (occlusion pressure equal or greater than 13 cmH2O) will be enrolled.
Patients will be placed in a 30°-45° head up position during all study phases. According to our institution protocol, pressure support setting will be selected by the attending physician to target a predefined tidal volume range of 6-8 mL/kg of predicted body weight (PBW) (female PBW [kg] = 45.5 + 0.91 [cm of height - 152.4]; male PBW [kg] = 50 + 0.91 [cm of height - 152.4]).The lowest pressure support level allowed will be 7 cmH2O, even if Vt <8 ml/Kg PBW is not achieved.
In each patient, four different ventilator settings will be applied in a random order. Each step will last 45 minutes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rome, Italy
- Fondazione Policlinico Universitaro A. Gemelli IRCCS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- (a) ARDS according to the Berlin definition (ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) ≤ 300 mmHg);
- (b) assisted ventilation, as prescribed by the attending physician
- (c) intense inspiratory effort, defined as a negative deflection in the airway pressure equal or greater than 13 cmH2O in the first breath recorded during an end-expiratory occlusion
Exclusion Criteria:
Pregnancy, clinically documented barotrauma, contraindication to electrical impedance tomography (EIT) use (e.g., presence of pacemaker or automatic implantable cardioverter defibrillator), impossibility to place the EIT belt in the right position (e.g., presence of surgical wounds dressing), and any contraindication to the insertion of a nasogastric tube (eg, recent upper-gastrointestinal surgery, esophageal varices), chest tubes with active air leaks, fever.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Low PEEP and full inspiratory synchronization
PEEP = 5 cmH2O + clinically selected pressure support (PSVclin)
|
Respiratory support through mechanical ventilator
|
|
EXPERIMENTAL: High PEEP and full inspiratory synchronization
PEEP = 15 cmH2O + clinically selected pressure support (PSVclin)
|
Respiratory support through mechanical ventilator
|
|
EXPERIMENTAL: Low PEEP and inspiratory desynchronization
PEEP = 5 cmH2O + bilevel positive airway pressure (Respiratory rate 15 breaths/minute, inspiratory time=1 sec, Inspiratory pressure=PSVclin+PEEP, PS=0 cmH2O)
|
Respiratory support through mechanical ventilator
|
|
EXPERIMENTAL: High PEEP and inspiratory desynchronization
PEEP = 15 cmH2O + bilevel positive airway pressure (Respiratory rate 15 breaths/minute, inspiratory time=1 sec, Inspiratory pressure=PSVclin+PEEP, PS=0 cmH2O)
|
Respiratory support through mechanical ventilator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inspiratory effort
Time Frame: 45 minutes
|
The negative deflection in esophageal pressure during inspiration
|
45 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygenation
Time Frame: 45 minutes
|
Ratio of PaO2 to FiO2
|
45 minutes
|
|
Respiratory mechanics
Time Frame: 45 minutes
|
Respiratory mechanics assessed by end-inspiratory occlusion
|
45 minutes
|
|
Lung mechanics
Time Frame: 45 minutes
|
Respiratory mechanics assessed by esophageal pressure monitoring during an end-inspiratory occlusion
|
45 minutes
|
|
Work of breathing
Time Frame: 45 minutes
|
Esopghageal pressure pressure-time product per minute
|
45 minutes
|
|
Respiratory rate
Time Frame: 45 minutes
|
Respiratory rate per minute
|
45 minutes
|
|
Regional Tidal volume distribution
Time Frame: 45 minutes
|
Distribution of tidal volume in the different lung zones, assessed by electrical impedance tomography
|
45 minutes
|
|
Alveolar recruitment
Time Frame: 45 minutes
|
Change in end-expiratory lung impedance, assessed by electrical impedance tomography
|
45 minutes
|
|
Pendelluft
Time Frame: 45 minutes
|
Occurrence of intra-tidal shift of gas within different lung regions at beginning of inspiration
|
45 minutes
|
|
Carbon dioxide
Time Frame: 45 minutes
|
Blood carbon dioxide, as assessed by arterial blood gas analysis
|
45 minutes
|
|
Tidal volume
Time Frame: 45 minutes
|
Average Tidal volume received by the patient
|
45 minutes
|
|
Dynamic transpulmonary driving pressure
Time Frame: 45 minutes
|
The average positive swing in transpulmonary driving pressure during tidal breathing
|
45 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Giuseppe Bello, MD, Fondazione Policlinico A. Gemelli IRCCS
- Study Director: Massimo Antonelli, MD, Fondazione Policlinico A. Gemelli IRCCS
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EARDS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.